43 results
8-K
EX-99.2
CRNX
Crinetics Pharmaceuticals Inc
3 Jun 24
Regulation FD Disclosure
4:35pm
Endocrinology & Metabolism.
“The depth and breadth of our clinical development program for once-daily, oral paltusotine under investigation
8-K
EX-10.1
CRNX
Crinetics Pharmaceuticals Inc
1 Mar 24
Crinetics Pharmaceuticals Announces Oversubscribed $350 Million Private Placement
4:07pm
of any claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action from the FDA or any governmental entity … that the FDA or any governmental entity or third party is considering any such claim, litigation, arbitration, action, suit, investigation or proceeding
8-K
EX-10.2
CRNX
Crinetics Pharmaceuticals Inc
1 Mar 24
Crinetics Pharmaceuticals Announces Oversubscribed $350 Million Private Placement
4:07pm
) or other entity of any kind.
“Proceeding” means an action, claim, suit, investigation or proceeding (including, without limitation, an investigation … , losses, damages, liabilities, penalties, judgments, costs (including, without limitation, costs of investigation) and expenses (including, without
8-K
EX-3.1
CRNX
Crinetics Pharmaceuticals Inc
12 Dec 23
Amendments to Articles of Incorporation or Bylaws
4:35pm
in writing as soon as practicable of any action, suit, proceeding or investigation involving such Indemnitee for which indemnity will or could be sought … . With respect to any action, suit, proceeding or investigation of which the Corporation is so notified, the Corporation will be entitled
8-K
EX-1.1
ckv4 lfege4s1tj
13 Sep 23
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
5:23pm
8-K
EX-1.1
4dq9i6ttdlqvwrm
13 Apr 22
Crinetics Pharmaceuticals Announces Pricing of Underwritten Common Stock Offering
4:26pm
8-K
EX-1.1
0s2r8
21 Oct 21
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:24pm
S-3ASR
EX-4.4
q3edxoi4
10 Aug 21
Automatic shelf registration
5:25pm
S-3ASR
0z5 tzeooo7nh
10 Aug 21
Automatic shelf registration
5:25pm
8-K
EX-1.1
0riyd4xq5g6 25e
8 Apr 21
Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock
4:09pm
8-K
EX-1.1
1apjzds x7pg30t944
15 Apr 20
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:06pm